Current widely-used antitubercular chemotherapy regimens (report)
Anastasatu, C.; Bercea, O.; Gartner, A.
Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Pneumoftiziologia 25(2): 85-91
1976
ISSN/ISBN: 0377-5011 PMID: 181830 Document Number: 109018
Document emailed within 1 workday
Related Documents
Radenbach, K.L. 1973: Current status of the antitubercular chemotherapy Der Internist 14(3): 100-110Khomenko, A.G.; Shmelev, N.A.; Stepanian, E.S.; Priss, I.S.; Koviazina, A.I. 1976: Side effects of antitubercular agents and current methods of detection of drug allergy in chemotherapy of tuberculosis Problemy Tuberkuleza 3: 18-24
Baba, H.; Shinkai, A.; Azuma, Y. 1979: Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis. (Report 2)--Results at one year after completing chemotherapy--(author's transl) Kekkaku: 54(1): 29-36
Tomioka, H.; Tada, A. 2010: Can we have adequate chemotherapy regimens for tuberculosis in the future? Current status and future prospects for development of new antituberculosis drugs Kekkaku: 85(2): 113-123
Katsumori, T.; Yamamoto, S.; Tsukamoto, Y.; Hamaguchi, H.; Iwanaga, T.; Ohshima, H. 2014: A case report of scirrhous gastric cancer with peritoneal dissemination treated effectively with various chemotherapy regimens after laparoscopic distal subtotal gastrectomy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(12): 2367-2368
Khomenko, I.S.; Chukanov, V.I.; Gergert, V.I.; Utkin, V.V. 1990: Effectiveness of antitubercular chemotherapy combined with corticosteroids and immunomodulators Problemy Tuberkuleza 1: 24-28
Roussel, G.; Sainte-Laudy, J. 1983: Allergy to the principal antitubercular drugs incompatible with the continuation of chemotherapy Presse Medicale 12(31): 1940
Serban, G.; Creţu, D. 1989: The evaluation of short-duration antitubercular chemotherapy (6 months) in rural areas Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Pneumoftiziologia 38(4): 368-371
Vladimirskiĭ, M.A.; Strel'tsov, V.P.; Stapanov, V.M.; Braude, V.I. 1980: Liposomes as vehicles of antitubercular drugs - a new appraoch to experimental chemotherapy of tuberculosis Problemy Tuberkuleza 7: 53-56
Didilescu, C.; Nicola, V. 1986: Factors with a negative effect on the success of short-term antitubercular chemotherapy under operational conditions Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Pneumoftiziologia 35(1): 89-91
Sosnowski, W.; Kubiak, Z. 1972: Early and late results of massive antitubercular chemotherapy in previously untreated pulmonary tuberculosis in adults Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 40(1): 21-28
Abi-Aad, A.S. 1996: Chemotherapy for advanced bladder carcinoma: new molecules and regimens Acta Urologica Belgica 64(2): 43-45
Raghavan, D.; Pearson, B.; Watt, W.H.; Mameghan, H.; Langdon, P.; Eisinger, D.; Wines, R. 1991: Cytotoxic chemotherapy for advanced bladder cancer: cisplatin-containing regimens Seminars in Oncology 18(1 Suppl 3): 56-63
Homesley, H.D. 1994: Development of single-agent chemotherapy regimens for gestational trophoblastic disease Journal of Reproductive Medicine 39(3): 185-192
Conti, F.; Sergi, D.; Foggi, P.; Abbate, M.I.; Lopez, M. 2007: New combination chemotherapy regimens in the primary treatment of operable breast cancer La Clinica Terapeutica 158(1): 55-75
Kitada, N.; Nishino, M.; Yasuda, J.; Morita, S.; Fujii, C.; Minegaki, T.; Kondoh, M.; Anami, S.; Takara, K.; Watari, M. 2009: Equalization of breast cancer chemotherapy at general hospital( Ii )-evaluation of safety in FEC and TC regimens Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(10): 1671-1675
Pérez-Stable, E.J.; Hopewell, P.C. 1989: Current tuberculosis treatment regimens. Choosing the right one for your patient Clinics in Chest Medicine 10(3): 323-339
Santoro, A.; Viviani, S.; Villarreal, C.J.; Bonfante, V.; Delfino, A.; Valagussa, P.; Bonadonna, G. 1986: Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP Cancer Treatment Reports 70(3): 343-348
Dubey, S.; Brown, R.L.; Esmond, S.L.; Bowers, B.J.; Healy, J.M.; Schiller, J.H. 2005: Patient preferences in choosing chemotherapy regimens for advanced non-small cell lung cancer Journal of Supportive Oncology 3(2): 149-154
Igawa, S.; Takahashi, T.; Nakamura, Y.; Tsuya, A.; Ono, A.; Shukuya, T.; Shukuya, T.; Murakami, H.; Endo, M.; Yamamoto, N. 2008: Efficacy of amrubicin for non-small cell lung cancer after failure of two or more prior chemotherapy regimens Anticancer Research 28(6b): 3855-3858